Please enable Javascript to get a taste of that Hopium 👼

ARCT - Company Overview - Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc
NASDAQ: arct

$34.78

USD

-$3.68

-9.57%

Prev Close

$38.46

Today's Open

$38.50

Volume

494.46K

Market Cap

916.82M

Day Range

34.56

range triangle

39.02

52W Range

24.87

range triangle

89.18

Overview

Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.

Read more
Current Price
15 min delay
Catalysts

There are currently no catalysts for ARCT. If there's something you'd like to see, feel free to reach out to us on discord.

Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)

Insufficient Data

Ratios
Valuation Ratios

EPS (TTM)

-7.55

P/E Ratio

0

Price to Sales

110.83

Price to Book

3.517

Profit Ratios

Profit Margin

0.00%

EBITDA Margin

-130.32%

Net Profit Margin

-548.76%

ROA

-32.40%

Total Revenue

$8.80M

Net Profit

-$48.31M

EV to EBITDA

0

EV to Revenue

64.14

Data source(s): Alpha Vantage